BOLT
Price:
$4.56
Market Cap:
$8.76M
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indicati...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
BOLT
According to Bolt Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.46M. This represents a change of -4.40% compared to the average of 20.36M of the last 4 quarters.
The mean historical Enterprise Value of Bolt Biotherapeutics, Inc. over the last ten years is 4.45B. The current 19.46M Enterprise Value has changed -56.30% with respect to the historical average. Over the past ten years (40 quarters), BOLT's Enterprise Value was at its highest in in the March 2021 quarter at 22.44B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.
Average
4.45B
Median
1.11B
Minimum
21.48M
Maximum
23.31B
Discovering the peaks and valleys of Bolt Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 354.80%
Maximum Annual Enterprise Value = 23.31B
Minimum Annual Increase = -94.96%
Minimum Annual Enterprise Value = 21.48M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 21.48M | -94.96% |
| 2024 | 426.57M | -50.19% |
| 2023 | 856.40M | -13.03% |
| 2022 | 984.69M | -73.11% |
| 2021 | 3.66B | -84.29% |
| 2020 | 23.31B | 354.80% |
| 2019 | 5.13B | 314.63% |
The current Enterprise Value of Bolt Biotherapeutics, Inc. (BOLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
434.82M
5-year avg
1.19B
10-year avg
4.45B
Bolt Biotherapeutics, Inc.’s Enterprise Value is greater than Cellectar Biosciences, Inc. (299.98K), greater than Sensei Biotherapeutics, Inc. (-133840780.00), greater than AEON Biopharma, Inc. (5.03M), greater than Cingulate Inc. (8.89M), greater than Imunon, Inc. (1.21M), greater than Lyra Therapeutics, Inc. (15.15M), greater than Marker Therapeutics, Inc. (-14642.00), greater than TransCode Therapeutics, Inc. (-7770350.00), greater than Evogene Ltd. (-1576119.83), greater than IN8bio, Inc. (-12958522.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 299.98K | $7.12M | |
| -133840780.00 | $17.45M | |
| 5.03M | $8.64M | |
| 8.89M | $27.36M | |
| 1.21M | $5.09M | |
| 15.15M | $781.13K | |
| -14642.00 | $14.90M | |
| -7770350.00 | $5.07M | |
| -1576119.83 | $5.03M | |
| -12958522.00 | $6.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bolt Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bolt Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bolt Biotherapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 3-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?
What is the 5-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?
How does the current Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT) compare to its historical average?